Not exhaustive, but highly practical
Keep all review within research-use-only boundaries.
The three REIMAGINE trials, published simultaneously in The Lancet Diabetes & Endocrinology (REIMAGINE 1 and 2) and The Lancet (REIMAGINE 3), each met their primary endpoints for A1C reduction and confirmed secondary endpoints for weight loss across diverse type 2 diabetes populations
however they are allowed and are very popular in countries like Korea, Taiwan, Thailand, Malaysia and the Philippines
Typically, an IV session lasts somewhere between 30 minutes to an hour, allowing for the nutrients, hydration, or medications to be administered effectively